Greystone Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.25M Sell
25,542
-898
-3% -$307K 2.58% 9
2026
Q1
$9.3M Sell
26,440
-18,452
-41% -$6.58M 2.63% 8
2025
Q4
$14.7M Sell
44,892
-3,197
-7% -$1.01M 2.29% 13
2025
Q3
$13.6M Buy
48,089
+2,552
+6% +$740K 2.1% 17
2025
Q2
$12.7M Buy
45,537
+14,940
+49% +$4.23M 2.09% 17
2025
Q1
$9.53M Buy
30,597
+6,204
+25% +$1.83M 1.73% 25
2024
Q4
$6.36M Buy
24,393
+4,979
+26% +$1.48M 1.11% 38
2024
Q3
$6.26M Buy
+19,414
New +$6.35M 1.12% 39
2023
Q2
Sell
-2,083
Closed -$504K 107
2023
Q1
$504K Buy
+2,083
New +$511K 0.13% 73

Other funds holding AMGN

Greystone Financial Group's AMGN Position: Q2 2026 in Review

Greystone Financial Group reduced its Amgen (AMGN) stake by 3.4% in Q2 2026, selling an estimated $307K and leaving 25,542 shares worth $9.25M. The position accounts for 2.58% of the portfolio, ranked #9.

Greystone Financial Group first reported a position in AMGN in Q1 2023 and has held it in 9 quarters since. The position peaked at $14.7M in Q4 2025. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Greystone Financial Group held 25,542 shares of Amgen worth $9.25M as of Q2 2026.
  • Greystone Financial Group sold 898 Amgen shares in Q2 2026, an estimated $307K.
  • Amgen made up 2.58% of Greystone Financial Group's portfolio in Q2 2026, its #9 holding.
  • Greystone Financial Group first reported a position in Amgen in Q1 2023 and has held it in 9 quarters since.
  • Greystone Financial Group's Amgen position peaked at $14.7M in Q4 2025.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Greystone Financial Group's 13F filing for Q2 2026, filed 28 Jul 2026.